LSU officials in high-level discussions about Brian Kelly's future after a 49-25 loss to Texas A&M, with a potential $53-$54 million buyout complicating any separation.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
U.S. and China finalize TikTok transfer deal, part of broader agreement
LSU officials in high-level discussions about Brian Kelly's future after a 49-25 loss to Texas A&M, with a potential $53-$54 million buyout complicating any separation.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
U.S. and China finalize TikTok transfer deal, part of broader agreement